Dr. David Block, MD

NPI: 1346302064
Total Payments
$13,623
2024 Payments
$2,069
Companies
5
Transactions
33

Payment Breakdown by Category

Other$8,316 (61.0%)
Consulting$4,148 (30.4%)
Food & Beverage$1,075 (7.9%)
Travel$50.90 (0.4%)
Education$33.12 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $8,316 9 61.0%
Consulting Fee $4,148 3 30.4%
Food and Beverage $1,075 18 7.9%
Travel and Lodging $50.90 1 0.4%
Education $33.12 2 0.2%

Top Paying Companies

Company Total Records Latest Year
Otsuka Pharmaceutical Development & Commercialization, Inc. $11,275 22 $0 (2024)
Otsuka America Pharmaceutical, Inc. $2,214 5 $0 (2023)
Janssen Pharmaceuticals, Inc $60.74 3 $0 (2024)
Teva Pharmaceuticals USA, Inc. $60.66 2 $0 (2024)
Sunovion Pharmaceuticals Inc. $13.00 1 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,069 6 Otsuka Pharmaceutical Development & Commercialization, Inc. ($1,971)
2023 $1,941 4 Otsuka Pharmaceutical Development & Commercialization, Inc. ($1,917)
2022 $2,630 4 Otsuka America Pharmaceutical, Inc. ($2,157)
2021 $1,620 1 Otsuka Pharmaceutical Development & Commercialization, Inc. ($1,620)
2020 $2,309 4 Otsuka Pharmaceutical Development & Commercialization, Inc. ($2,296)
2019 $98.61 1 Otsuka Pharmaceutical Development & Commercialization, Inc. ($98.61)
2018 $2,443 8 Otsuka Pharmaceutical Development & Commercialization, Inc. ($2,386)
2017 $512.82 5 Otsuka Pharmaceutical Development & Commercialization, Inc. ($512.82)

All Payment Transactions

33 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
10/17/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $24.87 General
Category: Central Nervous System
08/08/2024 Teva Pharmaceuticals USA, Inc. UZEDY (Drug) Food and Beverage In-kind items and services $35.79 General
Category: Neurology
06/18/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $16.26 General
Category: Neuroscience
06/05/2024 Otsuka Pharmaceutical Development & Commercialization, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $351.00 General
03/15/2024 Otsuka Pharmaceutical Development & Commercialization, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,620.00 General
02/08/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $20.82 General
Category: Neuroscience
12/13/2023 Otsuka America Pharmaceutical, Inc. ABILIFY ASIMTUFII (Drug) Food and Beverage In-kind items and services $23.53 General
Category: PSYCHIATRY
07/07/2023 Otsuka Pharmaceutical Development & Commercialization, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $351.00 General
04/05/2023 Otsuka Pharmaceutical Development & Commercialization, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $351.00 General
03/22/2023 Otsuka Pharmaceutical Development & Commercialization, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,215.00 General
04/22/2022 Otsuka America Pharmaceutical, Inc. Travel and Lodging Cash or cash equivalent $50.90 General
04/20/2022 Otsuka America Pharmaceutical, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,106.00 General
04/15/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Food and Beverage In-kind items and services $121.92 General
02/18/2022 Otsuka Pharmaceutical Development & Commercialization, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $351.00 General
08/13/2021 Otsuka Pharmaceutical Development & Commercialization, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,620.00 General
09/01/2020 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $1,890.00 General
05/29/2020 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $13.00 General
Category: CNS
01/30/2020 Otsuka Pharmaceutical Development & Commercialization, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $351.00 General
01/29/2020 Otsuka Pharmaceutical Development & Commercialization, Inc. Food and Beverage In-kind items and services $54.80 General
03/19/2019 Otsuka Pharmaceutical Development & Commercialization, Inc. ABILIFY MAINTENA (Drug) Food and Beverage In-kind items and services $98.61 General
Category: PSYCHIATRY
12/26/2018 Otsuka Pharmaceutical Development & Commercialization, Inc. Consulting Fee Cash or cash equivalent $2,082.60 General
11/14/2018 Otsuka Pharmaceutical Development & Commercialization, Inc. Food and Beverage In-kind items and services $82.93 General
11/12/2018 Otsuka Pharmaceutical Development & Commercialization, Inc. Food and Beverage In-kind items and services $32.50 General
11/09/2018 Otsuka America Pharmaceutical, Inc. Education In-kind items and services $16.56 General
11/09/2018 Otsuka America Pharmaceutical, Inc. Education In-kind items and services $16.56 General

About Dr. David Block, MD

Dr. David Block, MD is a Psychiatry healthcare provider based in San Bernardino, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346302064.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Block, MD has received a total of $13,623 in payments from pharmaceutical and medical device companies, with $2,069 received in 2024. These payments were reported across 33 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($8,316).

Practice Information

  • Specialty Psychiatry
  • Location San Bernardino, CA
  • Active Since 12/16/2006
  • Last Updated 12/17/2020
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • NPI Number 1346302064

Products in Payments

  • ABILIFY MAINTENA (Drug) $192.57
  • INVEGA SUSTENNA (Drug) $60.74
  • UZEDY (Drug) $35.79
  • Austedo XR (Drug) $24.87
  • ABILIFY ASIMTUFII (Drug) $23.53
  • LATUDA (Drug) $13.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in San Bernardino